Intraventricular immunovirotherapy; a translational step forward
Sign Up to like & getrecommendations! Published in 2023 at "Oncotarget"
DOI: 10.18632/oncotarget.28343
Abstract: Oncolytic virotherapy with intratumoral engineered type-1 herpes simplex virus (HSV) has been proven safe with promising efficacy in recent clinical trials for treatment of both pediatric and adult high-grade glioma. However, this approach excludes patients… read more here.
Keywords: translational step; step forward; intraventricular immunovirotherapy; immunovirotherapy translational ... See more keywords